|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Nutritional Epidemiology Unit, French Institute of Health and Medical Research (INSERM U557), UMR (INSERM/INRA/CNAM), CRNH Ile-de-France, Bobigny, France (SC, AC, SB, A-CV, LD, PG, and SH); and the Department of Nutrition, Hôtel-Dieu Hospital, Paris, France (AP-HP)
Background: Observational data suggest a protective effect of several antioxidants on fasting plasma glucose (FPG) and type 2 diabetes. However, randomized trials have yielded inconsistent results.
Objectives: The first objective was to assess the effect of 7.5 y of antioxidant supplementation on FPG at 7.5 y. The second objective was to examine the epidemiologic association of baseline dietary intakes or plasma antioxidants and FPG (at baseline and at 7.5 y).
Design: Subjects (n = 3146) from the Supplementation en Vitamines et Minéraux Antioxydants (SU.VI.MAX) primary prevention trial in France were randomly assigned to receive a daily capsule containing 120 mg vitamin C, 30 mg vitamin E, 6 mg ß-carotene, 100 µg Se, and 20 mg Zn or a placebo.
Results: After 7.5 y, no significant difference was observed between age-adjusted mean FPG in men (P = 0.78) and women (P = 0.89) in either group. Baseline ß-carotene dietary intakes and plasma concentrations were inversely associated with FPG in multivariate mixed models (P = 0.0045 and P < 0.0001, respectively). Baseline plasma vitamin C and selenium were negatively (P = 0.0455) and positively (P < 0.0001) associated, respectively, with FPG.
Conclusions: Supplementation with antioxidants at nutritional doses for 7.5 y had no effect on FPG in men or women who followed a balanced diet. An inverse association of baseline ß-carotene dietary intake and plasma concentrations with FPG was found, probably because ß-carotene is an indirect marker of fruit and vegetable intakes.
Key Words: Antioxidant supplementation ß-carotene fasting plasma glucose cohort study
This article has been cited by other articles:
![]() |
S. Czernichow, A.-C. Vergnaud, P. Galan, J. Arnaud, A. Favier, H. Faure, R. Huxley, S. Hercberg, and N. Ahluwalia Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults Am. J. Clinical Nutrition, August 1, 2009; 90(2): 329 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Meydani and A. Azzi Diabetes risk: antioxidants or lifestyle? Am. J. Clinical Nutrition, August 1, 2009; 90(2): 253 - 254. [Full Text] [PDF] |
||||
![]() |
M. Ristow, K. Zarse, A. Oberbach, N. Kloting, M. Birringer, M. Kiehntopf, M. Stumvoll, C. R. Kahn, and M. Bluher Antioxidants prevent health-promoting effects of physical exercise in humans PNAS, May 26, 2009; 106(21): 8665 - 8670. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hercberg, S. Czernichow, and P. Galan Vitamin C Concentration and Type 2 Diabetes Mellitus Arch Intern Med, March 23, 2009; 169(6): 634 - 634. [Full Text] [PDF] |
||||
![]() |
N. Forouhi, A.-H. Harding, K.-T. Khaw, S. Bingham, and N. Wareham Support for Benefit of Physical Activity on Satiety, Weight Control, and Diabetes Risk--Reply Arch Intern Med, March 23, 2009; 169(6): 635 - 635. [Full Text] [PDF] |
||||
![]() |
N. Bashan, J. Kovsan, I. Kachko, H. Ovadia, and A. Rudich Positive and Negative Regulation of Insulin Signaling by Reactive Oxygen and Nitrogen Species Physiol Rev, January 1, 2009; 89(1): 27 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Balkau, C. Lange, L. Fezeu, J. Tichet, B. de Lauzon-Guillain, S. Czernichow, F. Fumeron, P. Froguel, M. Vaxillaire, S. Cauchi, et al. Predicting Diabetes: Clinical, Biological, and Genetic Approaches: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) Diabetes Care, October 1, 2008; 31(10): 2056 - 2061. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stranges, J. R. Marshall, R. Natarajan, R. P. Donahue, M. Trevisan, G. F. Combs, F. P. Cappuccio, A. Ceriello, and M. E. Reid Effects of Long-Term Selenium Supplementation on the Incidence of Type 2 Diabetes: A Randomized Trial Ann Intern Med, August 21, 2007; 147(4): 217 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bleys, A. Navas-Acien, and E. Guallar Selenium and Diabetes: More Bad News for Supplements Ann Intern Med, August 21, 2007; 147(4): 271 - 272. [Full Text] [PDF] |
||||
![]() |
J. Bleys, A. Navas-Acien, and E. Guallar Serum Selenium and Diabetes in U.S. Adults Diabetes Care, April 1, 2007; 30(4): 829 - 834. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |